These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1818133)

  • 21. Sensitized CD8+ T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocystis carinii pneumonia.
    Gigliotti F; Crow EL; Bhagwat SP; Wright TW
    Infect Immun; 2006 Nov; 74(11):6310-6. PubMed ID: 16940142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection.
    Garvy BA; Ezekowitz RA; Harmsen AG
    Infect Immun; 1997 Feb; 65(2):373-9. PubMed ID: 9009285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice.
    Wiley JA; Harmsen AG
    J Immunol; 1995 Oct; 155(7):3525-9. PubMed ID: 7561048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latency is not an inevitable outcome of infection with Pneumocystis carinii.
    Chen W; Gigliotti F; Harmsen AG
    Infect Immun; 1993 Dec; 61(12):5406-9. PubMed ID: 7901169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Presence of Pneumocystis carinii and Pneumocystis wakefieldiae DNA in the extrapulmonary tissues of immunocompromised laboratory rats].
    Gołab E
    Wiad Parazytol; 2009; 55(2):167-71. PubMed ID: 19670532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic fatal pneumocystosis in nude mice.
    Ueda K; Goto Y; Yamazaki S; Fujiwara K
    Jpn J Exp Med; 1977 Dec; 47(6):475-82. PubMed ID: 305493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-gamma and type 1 and 2 TNF receptor genes.
    Rudmann DG; Preston AM; Moore MW; Beck JM
    J Immunol; 1998 Jul; 161(1):360-6. PubMed ID: 9647244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental Pneumocystis carinii pneumonia in C3H/HeJ and C3HeB/FeJ mice.
    Walzer PD; Rutledge ME; Yoneda K
    J Reticuloendothel Soc; 1983 Jan; 33(1):1-9. PubMed ID: 6601189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemistry of Pneumocystis carinii infection.
    Radio SJ; Hansen S; Goldsmith J; Linder J
    Mod Pathol; 1990 Jul; 3(4):462-9. PubMed ID: 2217151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inoculated mouse model of Pneumocystis carinii pneumonia.
    Bartlett MS; Queener SF; Durkin MM; Shaw MM; Smith JW
    J Protozool; 1991; 38(6):130S-131S. PubMed ID: 1818136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of Pneumocystis carinii infection in research mouse colonies in Japan.
    Serikawa T; Kitada K; Muraguchi T; Yamada J
    Lab Anim Sci; 1991 Oct; 41(5):411-4. PubMed ID: 1666138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pneumocystis carinii pneumonia in scid mice induced by viable organisms propagated in vitro.
    Beck JM; Newbury RL; Palmer BE
    Infect Immun; 1996 Nov; 64(11):4643-7. PubMed ID: 8890219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal T cells in an adult lung environment are competent to resolve Pneumocystis carinii pneumonia.
    Qureshi MH; Garvy BA
    J Immunol; 2001 May; 166(9):5704-11. PubMed ID: 11313412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts.
    Dumoulin A; Mazars E; Seguy N; Gargallo-Viola D; Vargas S; Cailliez JC; Aliouat EM; Wakefield AE; Dei-Cas E
    Eur J Clin Microbiol Infect Dis; 2000 Sep; 19(9):671-8. PubMed ID: 11057500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection.
    Chen W; Havell EA; Harmsen AG
    Infect Immun; 1992 Apr; 60(4):1279-84. PubMed ID: 1548057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumocystis carinii pneumonia in four mammal species: histopathology and ultrastructure.
    Creusy C; Bahon-le Capon J; Fleurisse L; Mullet C; Dridba M; Cailliez JC; Antoine M; Camus D; Dei-Cas E
    J Eukaryot Microbiol; 1996; 43(5):47S-48S. PubMed ID: 8822850
    [No Abstract]   [Full Text] [Related]  

  • 37. Delayed inflammatory response to Pneumocystis carinii infection in neonatal mice is due to an inadequate lung environment.
    Garvy BA; Qureshi MH
    J Immunol; 2000 Dec; 165(11):6480-6. PubMed ID: 11086088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Numbers of alveolar macrophages are increased during Pneumocystis pneumonia in mice.
    Lasbury ME; Durant PJ; Lee CH
    J Eukaryot Microbiol; 2003; 50 Suppl():637-8. PubMed ID: 14736195
    [No Abstract]   [Full Text] [Related]  

  • 39. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response.
    Chen W; Havell EA; Gigliotti F; Harmsen AG
    Infect Immun; 1993 Jan; 61(1):97-102. PubMed ID: 8418070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumocystosis in humans or in corticosteroid-untreated animal models: interactions between pulmonary surfactant changes and Pneumocystis carinii in vivo or in vitro growth.
    Prevost MC; Aliouat EM; Escamilla R; Dei-Cas E
    J Eukaryot Microbiol; 1997; 44(6):58S. PubMed ID: 9508443
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.